Abstract Churg-Strauss syndrome is a relapsing-remitting vasculitis that frequently involves digestive system. Ischemic perforation of the large bowel is relatively rare and potentially life threatening. We report a case treated with high dose of steroids for a relapsing of Churg-Strauss vasculopathy that underwent emergency surgery for multiple large-bowel perforations. Massive use of steroids is common for controlling relapse of this disease, but this increases the risk of intestinal perforation. A prompt switching to alternative drugs when intestinal tract is involved should be considered in order to prevent surgery.
A 69-year-old man with a 5-year history of severe ChurgStrauss syndrome (CSS) was admitted to emergency department because of abdominal pain, respiratory and cardiac insufficiency and a new worsening of oral aphthae. He reported a 5-day history of continuous diarrhea and an episode of rectal bleeding 2 days before. It was considered as a relapse of CSS. Abdominal X-ray was normal and a steroid pulse was given (900 mg of methyl-prednisolone). Two days after the admission, the patient complained of an acute diffuse abdominal pain and TC scan showed free air in sub-diaphragmatic region (Fig. 2) . We performed an emergency laparotomy finding multiple colonic perforations localized in the right and transverse colon. Resection of right and transverse colon with an end-type ileostomy was performed.
Multiple ulcers, extravasal granulomas and mucosal pseudo-polyps were found in the specimen (Fig. 2) . Bowel function through ileostomy took place on the second postoperative day and oral feeding was started on the fifth day. Laparotomy wound infection occurred on the fourth postoperative day. It was successfully treated with antibiotics and vacuum assisted closure (VAC) therapy. One month later the patient was discharged in good general condition and with normal ileostomy function (Fig. 1) .
Discussion
Churg-Strauss syndrome is a rare vasculitis that affects small to medium sized vessels associated with asthma and eosinophilia [1] . In 1990 the American College of Rheumatology proposed six criteria for classifying CSS with four being necessary to be diagnosed with a sensitivity of 85% and a specificity of 99.7% [2] . These criteria are asthma, eosinophilia greater than 10% on differential white blood cell count, mononeuropathy (including multiplex) or polyneuropathy, migratory or transient pulmonary infiltrates detected radiographically, paranasal sinus abnormality and biopsy containing a blood vessel with extravascular eosinophils [1] .
Gastrointestinal system is involved in almost 31% of patients and it is one of the poor-prognostic factors best known [3] . Small bowel appears to be more frequently involved (Table 1 ) [4] [5] [6] . Clinical manifestations of bowel localization usually consist of abdominal pain and gastrointestinal disorders [7] . Ulcerations are often found in endoscopy and they are considered as precursors of perforation. Review of previous publications and distribution of gastrointestinal tract involvement are reported in Table 1 . Up to now 18 cases of large bowel involvement are reported, most of them by Japanese authors [5] .
Corticosteroids are the cornerstone of initial treatment of CSS [7] . Massive steroid therapy is often used to control disease relapsing, as reported in Table 1 , but corticosteroids itself enhances fibrotic changes of the intimal tissue, which could consequently cause intestinal perforation due to vascular obstruction [8] . So it can create an environmental predisposition to perforation and mask its initial symptoms. A resection of necrotic intestinal tract is necessary when perforation is confirmed. Recently, alternative immunosuppressive therapies are used to treat patients with poor-prognostic factors, or predisposed to relapsing [3, 7] . These drugs and their indications are reported in Table 2 .
Switching to immunosuppressors should be promptly considered when critical gastrointestinal involvement is showed by symptoms or endoscopy in order to reduce the evolution to perforation, and consequently, the number of surgical resections. Moreover, during CSS relapses or when a poor-prognostic factor is already assessed like in our case. Further studies, recruiting a bigger number of patients with poor-prognostic factors, are needed to confirm the effective possibility of the therapeutic switch to avoid emergency surgery.
